{
    "2018-02-08": [
        [
            {
                "time": "",
                "orginal_text": "2017全球新药研发大年，中国创纪录",
                "features": {
                    "keywords": [
                        "新药研发",
                        "全球",
                        "中国",
                        "创纪录"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "中国：医疗保健：国家食药监局优先审评令新产品周期加速",
                "features": {
                    "keywords": [
                        "国家食药监局",
                        "优先审评",
                        "新产品",
                        "周期加速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "三路援军围剿大空头：“全线通杀”之后A股能否逆袭？",
                "features": {
                    "keywords": [
                        "三路援军",
                        "大空头",
                        "全线通杀",
                        "A股",
                        "逆袭"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "沪指创近半年新低，创业板逆势上涨1.5%",
                "features": {
                    "keywords": [
                        "沪指",
                        "新低",
                        "创业板",
                        "逆势上涨"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "指数表现"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "[推荐评级]医药生物行业深度研究：以AVASTIN为例看国内外贝伐珠单抗市场-创新药“工具书”系列之单抗(VEGF靶点)",
                "features": {
                    "keywords": [
                        "推荐评级",
                        "医药生物",
                        "AVASTIN",
                        "贝伐珠单抗",
                        "单抗",
                        "VEGF靶点"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "[强于大市评级]医药生物行业专题研究：500亿的PD-1/L1抗体市场空间是如何量化测算的",
                "features": {
                    "keywords": [
                        "强于大市评级",
                        "医药生物",
                        "PD-1/L1抗体",
                        "市场空间",
                        "量化测算"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}